Inhibition of meal stimulated gastric acid secretion by an octapeptide somatostatin analogue SMS 201-995.

A dose response study of the effect of an octapeptide somatostatin analogue, SMS 201-995, on meal stimulated gastric acid secretion was carried out in 12 healthy volunteers. Infusion of SMS 201-995 in a dose of 50 pmol/kg/h almost completely abolished the acid response to the meal. Pl-gastrin was significantly decreased during infusion of 10 pmol/kg/h of SMS 201-995 and insulin was significantly inhibited during infusion of 50 pmol/kg/h. SMS 201-995 in a dose of 50 pmol/kg/h inhibited basal and submaximal pentagastrin stimulated acid secretion by 77% and 84% respectively (p less than 0.01). On a molar basis SMS 201-995 is substantially more potent than natural somatostatin in inhibiting gastric acid secretion.

[1]  John R. Christiansen,et al.  Is somatostatin a humoral regulator of the endocrine pancreas and gastric acid secretion in man? , 1985, Gut.

[2]  K. Hine,et al.  SOMATOSTATIN IN TREATMENT OF HAEMATEMESIS AND MELAENA , 1985, The Lancet.

[3]  S. Lombardi,et al.  Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. , 1984, British medical journal.

[4]  P. Marbach,et al.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. , 1982, Life sciences.

[5]  M. Lewin,et al.  Intracellular receptor for somatostatin in gastric mucosal cells: decomposition and reconstitution of somatostatin-stimulated phosphoprotein phosphatases. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. D. Del Pozo,et al.  Endocrine effect of a methionine-enkephalin derivative (FK 33-824) in man. , 1980, Hormone research.

[7]  M. Wall,et al.  SOMATOSTATIN AND CIMETIDINE IN PEPTIC-ULCER HÆMORRHAGE A Randomised Controlled Trial , 1980, The Lancet.

[8]  J. Rehfeld,et al.  Somatostatin cell processes as pathways for paracrine secretion. , 1979, Science.

[9]  S. Efendić,et al.  Effects of intragastrically administered somatostatin on basal and pentagastrin stimulated gastric acid secretion in man. , 1978, Acta physiologica Scandinavica.

[10]  J. H. Baron,et al.  Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin. , 1978, Gut.

[11]  A. Schally,et al.  Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. , 1976, Gastroenterology.

[12]  J. Walsh,et al.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. , 1973, The Journal of clinical investigation.

[13]  A. Percival,et al.  Treatment of urinary-tract infections with amphicillin. A clinical trial. , 1962, Lancet.